Bruker Corp designs, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions used to study life and materials at microscopic, molecular, and cellular levels. The company is organized around four reportable segments: BioSpin, CALID, NANO, and BEST, which together span life science tools, applied and clinical analysis, nanoscale research, and energy/superconductor technologies. Its headquarters are in Billerica, Massachusetts, while major R&D and manufacturing operations are spread across Europe, Asia, and North America. Bruker sells into research, industrial, and diagnostic workflows where instrument performance, application support, and installed-base service are important to customer retention. The business also uses acquisitions to expand technology breadth, which has increased integration complexity and intangible asset exposure.
8,4 %
45,9 %
−0,3 %
+2,1 %
1.73
0.87
| % | |
|---|---|
| Scientific instruments | 80% Core laboratory instruments used for advanced analysis, measurement, and research across life and materials science. |
| Analytical and diagnostic solutions | 10% Systems and workflows that support molecular, cellular, and materials characterization in research and applied settings. |
| Service and other revenue | 10% Installation, maintenance, support, and other recurring revenue tied to the installed base. |
Bruker primarily sells to scientific and technical users that need highly specialized instrumentation rather than...
Universities, institutes, and public labs buy high-end instruments for basic and applied research in life and materials science.
Drug discovery and life science customers buy systems for molecular, cellular, and structural analysis to support R&D and validation.
Manufacturers and industrial R&D groups buy analytical tools for materials testing, quality control, and process development.
Applied and diagnostic customers buy instruments and solutions for laboratory workflows where accuracy and reproducibility matter.
Existing customers buy maintenance, support, and related services to keep complex instruments operating and compliant.
Bruker is headquartered in the United States but operates with a global footprint, including major R&D and...
Bruker’s strategy centers on expanding its technology portfolio in high-performance scientific instrumentation while...
Acquisitions add capabilities and market access, but they must be integrated well to create value and avoid margin dilution.
Scientific instrument customers buy on performance and application depth, so innovation is central to winning new platforms and protecting share.
Free cash flow supports capex, acquisitions, share repurchases, dividends, and debt repayment in a capital-intensive business.
Bruker faces execution risk from acquisitions because the company explicitly notes the need to identify suitable...
The company relies on acquisitions for technology expansion, but integration failures can raise costs, delay synergies, and distract management.
The company recorded a goodwill impairment charge for reporting units whose carrying values exceeded fair value under uncertain macro conditions.
Customers often buy instruments from grant, capex, or project budgets, which can shift timing and create quarterly volatility.
With manufacturing and commercial operations across multiple regions, currency movements and cross-border execution can affect results.
Outstanding debt and reliance on credit facilities can constrain flexibility if earnings or cash flow weaken.
BRKR · Laboratory Analytical Instruments
Bruker Corp designs, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions used to study life and…
EPI-A.ST · Industrials
LUND-B.ST · Financials
MEKO.ST · Consumer Discretionary
BUFAB.ST · Industrials
APOTEA.ST · Consumer Staples
: 11/08/2026